RI
Healthcare & Life Sciences
RheumaGen, Inc.
United States
RheumaGen, Inc. is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About RheumaGen, Inc.
Based in the United States, RheumaGen, Inc. is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
RheumaGen, Inc. is developing HLA-targeted gene-editing therapies aimed at treating major autoimmune diseases, supported by a $15 million Series A financing round.
Explore RheumaGen, Inc.'s full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.